Lista de obras - Dirk Reinhardt - Dominio Público Uruguay

1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α: Effect of Substituents in Position 3 of the Indole Scaffold on Inhibitory Potency, Metabolic Stability, Solubility, and Bioavailability ⬇️

artículo científico publicado el 10 de noviembre de 2010

ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport

artículo científico publicado en 2004

Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia

artículo científico publicado en 2012

Acute leukemias in children with Down syndrome

artículo científico publicado en 2008

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

artículo científico publicado en 2011

An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia

artículo científico publicado en 2018

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target ⬇️

artículo científico publicado el 3 de septiembre de 2012

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

artículo científico publicado en 2010

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

artículo científico publicado en 2012

Clinical implications of FLT3 mutations in pediatric AML.

artículo científico publicado en 2006

Clinical picture and differential diagnosis of cardiomyopathy and myocarditis ⬇️

artículo científico publicado el 15 de abril de 1998

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

artículo científico publicado en 2015

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view

artículo científico publicado en 2002

Development of a curative treatment within the AML-BFM studies ⬇️

artículo científico publicado el 22 de mayo de 2013

Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis

artículo científico publicado en 2010

Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia ⬇️

artículo científico publicado el 4 de agosto de 2011

Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?

artículo científico publicado en 2006

Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells

artículo científico publicado en 2013

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

artículo científico publicado en 2010

Gene expression profiles associated with pediatric relapsed AML.

artículo científico publicado en 2015

Genetic prognostic factors in childhood acute myeloid leukemia ⬇️

artículo científico publicado el 20 de julio de 2012

Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse

artículo científico publicado en 2010

Hemoglobin F in myelodysplastic syndrome ⬇️

artículo científico publicado el 1 de marzo de 1998

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study

artículo científico publicado en 2015

High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia ⬇️

artículo científico publicado el 11 de julio de 2012

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.

artículo científico publicado en 2006

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

artículo científico publicado en 2015

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 ⬇️

artículo científico publicado el 1 de enero de 2004

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

artículo científico publicado en 2021

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia

artículo científico publicado en 2011

LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia

artículo científico publicado en 2014

Long term survival in children with acute leukaemia and complications requiring mechanical ventilation

artículo científico publicado en 2011

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia

artículo científico publicado en 2016

Minimising the long-term adverse effects of childhood leukaemia therapy

artículo científico publicado en 2002

Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia

artículo científico publicado en 2019

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern ⬇️

artículo científico publicado el 2 de agosto de 2011

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.

artículo científico publicado en 2013

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

artículo científico publicado en 2007

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

artículo científico publicado en 2009

PHF6 mutations in paediatric acute myeloid leukaemia

artículo científico publicado en 2015

Paediatric palliative home care in areas of Germany with low population density and long distances: a questionnaire survey with general paediatricians

artículo científico publicado en 2012

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

artículo científico publicado en 2013

Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

artículo científico publicado en 2019

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

artículo científico publicado en 2011

Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia

artículo científico publicado en 2014

Quality management in implementing specialist pediatric palliative home care in Lower Saxony, Germany ⬇️

artículo científico publicado el 12 de mayo de 2012

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group

artículo científico publicado en 2023

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia

artículo científico publicado en 2015

Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited

artículo científico publicado en 2015

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

artículo científico publicado en 2014

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

artículo científico publicado en 2011

The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells ⬇️

artículo científico publicado el 29 de diciembre de 2011

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

artículo científico publicado en 2008

miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia

artículo científico publicado en 2010

Lista de obras de Dirk Reinhardt

1-(5-Carboxyindol-1-yl)propan-2-one Inhibitors of Human Cytosolic Phospholipase A2α: Effect of Substituents in Position 3 of the Indole Scaffold on Inhibitory Potency, Metabolic Stability, Solubility, and Bioavailability ⬇️

ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport

Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia

Acute leukemias in children with Down syndrome

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target ⬇️

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models

Clinical implications of FLT3 mutations in pediatric AML.

Clinical picture and differential diagnosis of cardiomyopathy and myocarditis ⬇️

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a European view

Development of a curative treatment within the AML-BFM studies ⬇️

Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis

Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia ⬇️

Does modulation of P-glycoprotein have clinical relevance in pediatric acute myeloid leukemia?

Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

Gene expression profiles associated with pediatric relapsed AML.

Genetic prognostic factors in childhood acute myeloid leukemia ⬇️

Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse

Hemoglobin F in myelodysplastic syndrome ⬇️

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study

High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia ⬇️

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 ⬇️

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia

LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia

Long term survival in children with acute leukaemia and complications requiring mechanical ventilation

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia

Minimising the long-term adverse effects of childhood leukaemia therapy

Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern ⬇️

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

PHF6 mutations in paediatric acute myeloid leukaemia

Paediatric palliative home care in areas of Germany with low population density and long distances: a questionnaire survey with general paediatricians

Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.

Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study

Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia

Quality management in implementing specialist pediatric palliative home care in Lower Saxony, Germany ⬇️

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia

Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells ⬇️

Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia